BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
12 results:

  • 1. Factors Associated with Survival in Anaplastic thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]    [Full Text] [Related]  

  • 2. Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary thyroid cancer.
    Zhou H; Wu J; Shi L; Wang Y; Liu B
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3389-3397. PubMed ID: 36056633
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    Kaliszewski K; Diakowska D; Nowak Ł; Wojtczak B; Rudnicki J
    BMC Cancer; 2020 Nov; 20(1):1166. PubMed ID: 33256657
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A glycolysis-related gene expression signature in predicting recurrence of breast cancer.
    Tang J; Luo Y; Wu G
    Aging (Albany NY); 2020 Nov; 12(24):24983-24994. PubMed ID: 33201835
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The relationship between anesthetic technique and thirty-day mortality in patients undergoing noncardiac- and nonneurosurgery: A retrospective, propensity score-matched cohort study.
    Luo X; Liu B; Li F; Zheng S; Li Y; Yang L; Gao R; Guo QY; Chen H; Huang K; Hu H; He J
    Int J Surg; 2020 May; 77():120-127. PubMed ID: 32234578
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor prognosis.
    Higa N; Shinsato Y; Kamil M; Hirano T; Takajo T; Shimokawa M; Minami K; Yamamoto M; Kawahara K; Yonezawa H; Hirano H; Furukawa T; Yoshimoto K; Arita K
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861134
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical Prognostic Score for Predicting Disease Remission with Differentiated thyroid cancers.
    Somboonporn C; Mangklabruks A; Thakkinstian A; Vatanasapt P; Nakaphun S
    Asian Pac J Cancer Prev; 2016; 17(6):2805-10. PubMed ID: 27356694
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
    Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
    Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Retrospective epidemiological study of thyroid nodules by ultrasound in asymptomatic subjects.
    Sharen G; Zhang B; Zhao R; Sun J; Gai X; Lou H
    Chin Med J (Engl); 2014; 127(9):1661-5. PubMed ID: 24791871
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
    Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
    Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.